Page last updated: 2024-12-05

butylurea

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Butylurea is an organic compound with the formula CH3(CH2)3NHCONH2. It is a white solid that is soluble in water. Butylurea can be synthesized by reacting butylamine with urea. Butylurea has been studied for its potential applications in various fields, including agriculture, medicine, and industry. For example, it has been investigated as a herbicide, a plant growth regulator, and a component of biodegradable polymers. The compound has also been explored for its potential as a therapeutic agent in the treatment of certain diseases. The biological activity of butylurea is attributed to its ability to interact with various biological targets, including enzymes and receptors. Its effects are often related to its ability to modulate cellular processes, such as growth, differentiation, and metabolism. Further research is ongoing to fully understand the mechanisms of action and potential applications of butylurea in various fields.'

butylurea: CNS depressant [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11595
CHEMBL ID3182932
SCHEMBL ID42513
SCHEMBL ID22493264
MeSH IDM0049680

Synonyms (46)

Synonym
n-butyl urea
unii-9cpl5nr15k
urea, n-butyl-
9cpl5nr15k ,
4-04-00-00578 (beilstein handbook reference)
wln: zvm4
nsc2597
urea, butyl-
nci-c02131
nsc-2597
1-butylurea
n-butylurea
592-31-4
butylurea
brn 1744775
hsdb 5497
nsc 2597
ai3-52319
einecs 209-748-4
n-butylurea, 99%
B1831 ,
AKOS000199394
NCGC00249150-01
tox21_302837
NCGC00256604-01
dtxcid20222
cas-592-31-4
dtxsid6020222 ,
tox21_202015
NCGC00259564-01
FT-0632462
n-butylurea [hsdb]
SCHEMBL42513
butyl-urea
butyl urea
n-n-butylurea
CHEMBL3182932
mfcd00007956
J-523529
F0001-1554
Q27272364
D88864
AS-56323
SCHEMBL22493264
EN300-20880
SY049645

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Some of the compounds have shown good oral bioavailability and half-life in rats."( Discovery of novel benzothiazolesulfonamides as potent inhibitors of HIV-1 protease.
Blystone, L; De Crescenzo, GA; Funkes-Shippy, CL; Getman, DP; Houseman, KA; Kishore, N; Kocan, GP; Lu, HF; McDonald, JJ; Mehta, PP; Nagarajan, SR; Sikorski, JA; Walker, JL, 2003
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency68.58960.003041.611522,387.1992AID1159552; AID1159555
pregnane X nuclear receptorHomo sapiens (human)Potency68.58960.005428.02631,258.9301AID1346982
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency12.15540.001024.504861.6448AID743215
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency54.94770.023723.228263.5986AID743241
heat shock protein beta-1Homo sapiens (human)Potency54.94770.042027.378961.6448AID743210; AID743228
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (58)

TimeframeStudies, This Drug (%)All Drugs %
pre-199047 (81.03)18.7374
1990's2 (3.45)18.2507
2000's5 (8.62)29.6817
2010's4 (6.90)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.07

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.07 (24.57)
Research Supply Index4.11 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.07)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other58 (96.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]